CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
Anne E BrasValerie de HaasArthur van StigtMojca Jongen-LavrencicH Berna BeverlooJeroen G Te MarveldeC Michel ZwaanJacques J M van DongenJeanette H W LeusenVincent H J van der VeldenPublished in: Cytometry. Part B, Clinical cytometry (2018)
Authors evaluated CD123 expression in a large cohort of acute leukemia patients, based on standardized and reproducible methodology. Our results may facilitate stratification of patients most likely to respond to CD123 targeted therapies and serve as reference for CD123 expression (in health and disease). © 2018 The Authors. Cytometry Part B: Clinical Cytometry published by Wiley Periodicals, Inc. on behalf of International Clinical Cytometry Society.